115 related articles for article (PubMed ID: 23786845)
1. Second-line therapy in advanced biliary tract cancer: what should be the standard?
Cereda S; Belli C; Rognone A; Mazza E; Reni M
Crit Rev Oncol Hematol; 2013 Nov; 88(2):368-74. PubMed ID: 23786845
[TBL] [Abstract][Full Text] [Related]
2. Current status of chemotherapy for the treatment of advanced biliary tract cancer.
Sasaki T; Isayama H; Nakai Y; Koike K
Korean J Intern Med; 2013 Sep; 28(5):515-24. PubMed ID: 24009445
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
4. FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
Moretto R; Raimondo L; De Stefano A; Cella CA; Matano E; De Placido S; Carlomagno C
Anticancer Drugs; 2013 Oct; 24(9):980-5. PubMed ID: 23928570
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
[TBL] [Abstract][Full Text] [Related]
6. Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure.
Onesti CE; Romiti A; Roberto M; Falcone R; Marchetti P
Expert Rev Anticancer Ther; 2015; 15(10):1183-98. PubMed ID: 26325474
[TBL] [Abstract][Full Text] [Related]
7. Second-line therapies in advanced biliary tract cancers.
Tella SH; Kommalapati A; Borad MJ; Mahipal A
Lancet Oncol; 2020 Jan; 21(1):e29-e41. PubMed ID: 31908303
[TBL] [Abstract][Full Text] [Related]
8. [Current status of adjuvant therapy for biliary tract cancer].
Kato A; Miyazaki M
Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):206-11. PubMed ID: 25154240
[TBL] [Abstract][Full Text] [Related]
9. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
10. Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations.
Neuzillet C; Casadei Gardini A; Brieau B; Vivaldi C; Smolenschi C; Brandi G; Tougeron D; Filippi R; Vienot A; Silvestris N; Pointet AL; Lonardi S; Rousseau B; Scartozzi M; Dahan L; Aprile G; Boussaha T; Malka D; Crusz SM; Le Sourd S; Meurisse A; Lièvre A; Vernerey D; ; ; ;
Eur J Cancer; 2019 Apr; 111():94-106. PubMed ID: 30826661
[TBL] [Abstract][Full Text] [Related]
11. Toward personalized treatment of advanced biliary tract cancers.
Geynisman DM; Catenacci DV
Discov Med; 2012 Jul; 14(74):41-57. PubMed ID: 22846202
[TBL] [Abstract][Full Text] [Related]
12. S-1 monotherapy in patients with advanced biliary tract cancer.
Sasaki T; Isayama H; Yashima Y; Yagioka H; Kogure H; Arizumi T; Togawa O; Matsubara S; Ito Y; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tada M; Kawabe T; Omata M
Oncology; 2009; 77(1):71-4. PubMed ID: 19556812
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in the biliary tract cancer treatment].
Andoh H; Tanaka Y; Hanaoka T
Nihon Rinsho; 2006 Jan; 64 Suppl 1():551-4. PubMed ID: 16457324
[No Abstract] [Full Text] [Related]
16. Advances in the treatment of metastatic or unresectable biliary tract cancer.
Valle JW
Ann Oncol; 2010 Oct; 21 Suppl 7():vii345-8. PubMed ID: 20943640
[TBL] [Abstract][Full Text] [Related]
17. [Management of biliary tract carcinomas].
Delbaldo C; Laurent A; Grenier J; Cherqui D; Luciani A; Piedbois P
Rev Prat; 2009 Apr; 59(4):469-73. PubMed ID: 19462864
[TBL] [Abstract][Full Text] [Related]
18. New Treatment Options for Advanced Biliary Tract Cancer.
Mizrahi JD; Shroff RT
Curr Treat Options Oncol; 2020 Jun; 21(8):63. PubMed ID: 32602010
[TBL] [Abstract][Full Text] [Related]
19. Biliary tract cancers: understudied and poorly understood.
Chan E; Berlin J
J Clin Oncol; 2015 Jun; 33(16):1845-8. PubMed ID: 25918294
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with unresectable advanced carcinoma of biliary tract - chemotherapy and surgical resection.
Morise Z; Sugioka A; Tanahashi Y; Okabe Y; Ikeda M; Kagawa T; Takeura C
Anticancer Res; 2009 May; 29(5):1783-6. PubMed ID: 19443404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
